163 related articles for article (PubMed ID: 10509574)
1. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study.
Anastos K; Kalish LA; Hessol N; Weiser B; Melnick S; Burns D; Delapenha R; DeHovitz J; Cohen M; Meyer W; Bremer J; Kovacs A
AIDS; 1999 Sep; 13(13):1717-26. PubMed ID: 10509574
[TBL] [Abstract][Full Text] [Related]
2. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
[TBL] [Abstract][Full Text] [Related]
3. The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l.
Coakley EP; Samore MH; Gillis JM; Hughes MD; Hammer SM
AIDS; 2000 Jun; 14(9):1147-53. PubMed ID: 10894278
[TBL] [Abstract][Full Text] [Related]
4. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Berhane K; Karim R; Cohen MH; Masri-Lavine L; Young M; Anastos K; Augenbraun M; Watts DH; Levine AM
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1245-52. PubMed ID: 15385731
[TBL] [Abstract][Full Text] [Related]
5. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection.
Cozzi Lepri A; Katzenstein TL; Ullum H; Phillips AN; Skinhøj P; Gerstoft J; Pedersen BK
AIDS; 1998 Sep; 12(13):1639-43. PubMed ID: 9764783
[TBL] [Abstract][Full Text] [Related]
6. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study.
Feldman JG; Burns DN; Gange SJ; Bacchetti P; Cohen M; Anastos K; Nowicki M; Delapena R; Miotti P
AIDS; 2000 May; 14(7):863-70. PubMed ID: 10839595
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users.
Tarwater PM; Gallant JE; Mellors JW; Gore ME; Phair JP; Detels R; Margolick JB; Muñoz A
AIDS; 2004 Dec; 18(18):2419-23. PubMed ID: 15622318
[TBL] [Abstract][Full Text] [Related]
8. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.
MacArthur RD; Perez G; Walmsley S; Baxter JD; Mullin CM; Neaton JD; ;
HIV Clin Trials; 2005; 6(3):127-35. PubMed ID: 16192247
[TBL] [Abstract][Full Text] [Related]
9. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
[TBL] [Abstract][Full Text] [Related]
10. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.
Palumbo PE; Raskino C; Fiscus S; Pahwa S; Fowler MG; Spector SA; Englund JA; Baker CJ
JAMA; 1998 Mar; 279(10):756-61. PubMed ID: 9508151
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.
Phillips AN; Eron JJ; Bartlett JA; Rubin M; Johnson J; Price S; Self P; Hill AM
AIDS; 1996 Jul; 10(8):859-65. PubMed ID: 8828743
[TBL] [Abstract][Full Text] [Related]
13. Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 x 10(6)/l.
Ruiz L; Romeu J; Clotet B; Balagué M; Cabrera C; Sirera G; Ibáñez A; Martínez-Picado J; Raventós A; Tural C; Segura A; Foz M
AIDS; 1996 Sep; 10(11):F39-44. PubMed ID: 8883577
[TBL] [Abstract][Full Text] [Related]
14. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients.
Valentine ME; Jackson CR; Vavro C; Wilfert CM; McClernon D; St Clair M; Katz SL; McKinney RE
Pediatr Infect Dis J; 1998 Jan; 17(1):18-23. PubMed ID: 9469389
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
Merigan TC; Hirsch RL; Fisher AC; Meyerson LA; Goldstein G; Winters MA
AIDS; 1996 Feb; 10(2):159-65. PubMed ID: 8838703
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
19. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels.
Ullum H; Lepri AC; Katzenstein TL; Phillips AN; Skinhøj P; Gerstoft J; Pedersen BK
Scand J Infect Dis; 2000; 32(4):371-6. PubMed ID: 10959644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]